Katalin Kariko and Drew Weissman yesterday won the Nobel Prize in Medicine for work on messenger RNA (mRNA) technology that paved the way for groundbreaking COVID-19 vaccines.
The pair, who had been tipped as favorites, “contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times,” the jury said.
The WHO declared COVID-19 a pandemic in March 2020 and the mRNA vaccines were approved for use in December that year. Billions of doses have been administered around the world since then.
Photo: AFP
Together with other COVID-19 vaccines, they “have saved millions of lives and prevented severe disease in many more,” the jury said.
Longstanding colleagues at the University of Pennsylvania in the US, adjunct professor of neurosurgery Kariko, 68, and Roberts family professor in vaccine research Weissman, 64, have won a slew of awards for their research. They include the prestigious Lasker Award in 2021, often seen as a precursor to the Nobel.
In honoring the pair this year, the Nobel committee in Stockholm broke with its usual practice of honoring decades-old research, after ensuring it has stood the test of time.
While the prizewinning research dates back to 2005, the first vaccines to use the mRNA technology were those made by Pfizer/BioNTech and Moderna against COVID-19.
Unlike traditional vaccines that use weakened virus or a key piece of the virus’ protein, mRNA vaccines provide the genetic molecules that tell cells what proteins to make, which simulates an infection and trains the immune system for when it encounters the real virus.
The idea was first demonstrated in 1990, but it was not until the mid-2000s that Weissman, of the US, and Hungarian-born Kariko developed a technique to control a dangerous inflammatory response seen in animals exposed to these molecules, opening the way to develop safe human vaccines.
The honor is particularly sweet for Kariko, the 13th woman to win the medicine prize, who toiled in obscurity for years and struggled to convince her superiors of the need for mRNA research.
Speaking to Swedish Radio, she said her late mother always had faith in her, listening to the Nobel prize announcements “year after year” in the hopes of hearing her daughter’s name called out.
“Unfortunately, five years ago she passed at the age of 89. She might be listening from above,” Kariko said.
Nobel Assembly secretary-general Thomas Perlmann called Kariko “an extraordinary and unusual scientist” who “resisted any temptation” to do “something easier.”
Weissman told Swedish Radio he heard the news from Kariko, who received the call from the jury first.
“We weren’t sure if somebody was playing a prank on us,” he said, adding that he would “probably go out with my family and have a nice dinner” to celebrate.
The pair’s mRNA technology is now being used to develop other treatments for diseases and illnesses such as cancer, influenza and heart failure.
They are to receive their Nobel prize, consisting of a diploma, a gold medal and US$1 million, in Stockholm on Dec. 10.
INSPIRING: Taiwan has been a model in the Asia-Pacific region with its democratic transition, free and fair elections and open society, the vice president-elect said Taiwan can play a leadership role in the Asia-Pacific region, vice president-elect Hsiao Bi-khim (蕭美琴) told a forum in Taipei yesterday, highlighting the nation’s resilience in the face of geopolitical challenges. “Not only can Taiwan help, but Taiwan can lead ... not only can Taiwan play a leadership role, but Taiwan’s leadership is important to the world,” Hsiao told the annual forum hosted by the Center for Asia-Pacific Resilience and Innovation think tank. Hsiao thanked Taiwan’s international friends for their long-term support, citing the example of US President Joe Biden last month signing into law a bill to provide aid to Taiwan,
STATE OF THE NATION: The legislature should invite the president to deliver an address every year, the TPP said, adding that Lai should also have to answer legislators’ questions The Chinese Nationalist Party (KMT) yesterday proposed inviting president-elect William Lai (賴清德) to make a historic first state of the nation address at the legislature following his inauguration on May 20. Lai is expected to face many domestic and international challenges, and should clarify his intended policies with the public’s representatives, KMT caucus secretary-general Hung Meng-kai (洪孟楷) said when making the proposal at a meeting of the legislature’s Procedure Committee. The committee voted to add the item to the agenda for Friday, along with another similar proposal put forward by the Taiwan People’s Party (TPP). The invitation is in line with Article 15-2
Premier Chen Chien-jen (陳建仁) and the Ministry of Foreign Affairs yesterday denounced Chinese Nationalist Party (KMT) Legislator Hsu Chiao-hsin (徐巧芯) for making false allegations about donations to Ukraine and disclosing confidential documents, with the ministry saying that it would take legal action. The ministry last year signed an agreement with the Czech Republic on a healthcare project to assist Ukraine, which is to be carried out by the Czech Health Technology Institute. Hsu accused the ministry of being indirectly involved in the party politics of the Czech Republic as institute chairman Petr Foit is a local medical supplier, and has close political
PLAN: Nations would receive US$5m a year if they could advance Taiwan’s international participation, diversify supply chains away from China or counter Beijing’s influence The US House of Representatives Select Committee on Strategic Competition Between the US and the Chinese Communist Party (CCP) on Friday introduced a bill that would approve US$120 million to be spent on supporting Taiwan’s international space and tackling coercion by China. The bipartisan legislation — the Taiwan Allies Fund Act — was proposed ahead of the inauguration of president-elect William Lai (賴清德) of the Democratic Progressive Party (DPP) on May 20. The committee said in a statement that the bill “strengthens Taiwan’s global network of friends by authorizing [US]$120 million over three years for the State Department and USAID [US Agency